PT-2385 Uses, Dosage, Side Effects and more

PT-2385 is under investigation in clinical trial NCT03108066 (PT2385 for the Treatment of Von Hippel-lindau Disease-associated Clear Cell Renal Cell Carcinoma).

Trade Name PT-2385
Generic PT-2385
Type
Formula C17H12F3NO4S
Weight Average: 383.34
Monoisotopic: 383.043913533
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share